Pictet Asset Management Sa Seres Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 13,692 shares of MCRB stock, worth $211,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,692
Previous 13,692
-0.0%
Holding current value
$211,404
Previous $77,000
15.58%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MCRB
# of Institutions
9Shares Held
1.98MCall Options Held
10KPut Options Held
0-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Miller Financial Services LLC Marshall, MI15KShares$231,6000.02% of portfolio
-
Jpmorgan Chase & CO New York, NY1.3KShares$20,1330.0% of portfolio
-
Sandy Spring Bank345Shares$5,3260.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ160Shares$2,4700.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...